ANETHOLTRITHION: 254 Adverse Event Reports & Safety Profile
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
254
Total FAERS Reports
12 (4.7%)
Deaths Reported
175
Hospitalizations
254
As Primary/Secondary Suspect
51
Life-Threatening
15
Disabilities
First Report: 20071024 · Latest Report: 20250627
What Are the Most Common ANETHOLTRITHION Side Effects?
#1 Most Reported
Fall
29 reports (11.4%)
#2 Most Reported
Faecaloma
23 reports (9.1%)
#3 Most Reported
Confusional state
19 reports (7.5%)
All ANETHOLTRITHION Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Fall | 29 | 11.4% | 1 | 27 |
| Faecaloma | 23 | 9.1% | 10 | 23 |
| Confusional state | 19 | 7.5% | 1 | 16 |
| Somnolence | 18 | 7.1% | 0 | 12 |
| Poisoning deliberate | 17 | 6.7% | 0 | 16 |
| Wrong patient received product | 17 | 6.7% | 0 | 3 |
| Extrapyramidal disorder | 16 | 6.3% | 1 | 15 |
| Pulmonary embolism | 16 | 6.3% | 0 | 16 |
| Neuroleptic malignant syndrome | 15 | 5.9% | 0 | 14 |
| Tachycardia | 14 | 5.5% | 0 | 0 |
| Impaired gastric emptying | 13 | 5.1% | 0 | 13 |
| Anaemia | 12 | 4.7% | 0 | 12 |
| Oedema peripheral | 12 | 4.7% | 0 | 12 |
| Colitis ischaemic | 11 | 4.3% | 0 | 6 |
| Hepatocellular injury | 11 | 4.3% | 0 | 8 |
| Product administration error | 11 | 4.3% | 0 | 2 |
| Completed suicide | 10 | 3.9% | 10 | 10 |
| Hypotension | 10 | 3.9% | 0 | 1 |
| Circumstance or information capable of leading to medication error | 9 | 3.5% | 0 | 0 |
| General physical health deterioration | 9 | 3.5% | 0 | 9 |
Who Reports ANETHOLTRITHION Side Effects? Age & Gender Data
Gender: 61.9% female, 38.1% male. Average age: 54.6 years. Most reports from: FR. View detailed demographics →
Is ANETHOLTRITHION Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2007 | 1 | 0 | 0 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 1 | 1 |
| 2013 | 3 | 0 | 1 |
| 2014 | 16 | 0 | 15 |
| 2015 | 17 | 0 | 8 |
| 2016 | 31 | 10 | 22 |
| 2017 | 10 | 0 | 10 |
| 2018 | 9 | 0 | 9 |
| 2019 | 26 | 1 | 7 |
| 2020 | 42 | 0 | 29 |
| 2021 | 19 | 0 | 18 |
| 2022 | 31 | 0 | 18 |
| 2023 | 21 | 0 | 18 |
| 2024 | 19 | 0 | 15 |
| 2025 | 1 | 0 | 0 |
What Is ANETHOLTRITHION Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 104 |
| Aptyalism | 57 |
| Dry mouth | 13 |
| Bipolar disorder | 7 |
| Product administration error | 7 |
| Prophylaxis | 7 |
| Schizophrenia | 6 |
| Chronic obstructive pulmonary disease | 5 |
| Dyspepsia | 5 |
ANETHOLTRITHION vs Alternatives: Which Is Safer?
ANETHOLTRITHION vs ANGIOTENSIN II
ANETHOLTRITHION vs ANHYDROUS CITRIC ACID\ASPIRIN\SODIUM BICARBONATE
ANETHOLTRITHION vs ANHYDROUS CITRIC ACID\MAGNESIUM\SODIUM PICOSULFATE
ANETHOLTRITHION vs ANIDULAFUNGIN
ANETHOLTRITHION vs ANIFROLUMAB
ANETHOLTRITHION vs ANIFROLUMAB-FNIA
ANETHOLTRITHION vs ANTHOXANTHUM ODORATUM POLLEN\DACTYLIS GLOMERATA POLLEN\LOLIUM PERENNE POLLEN\PHLEUM PRATENSE POLLEN\POA PRATENSIS POLLEN
ANETHOLTRITHION vs ANTI-INHIBITOR COAGULANT COMPLEX
ANETHOLTRITHION vs ANTIHEMOPHILIC FACTOR HUMAN
ANETHOLTRITHION vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
Official FDA Label for ANETHOLTRITHION
Official prescribing information from the FDA-approved drug label.